Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins.

KNI-272 represents a peptide-based protease inhibitor having potent antiretroviral activity against human immunodeficiency virus (HIV) in vitro. The structure contains allophenylnorstatine [(2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid] with a hydroxymethylcarbonyl isostere. We asked whether this e...

詳細記述

保存先:

書誌詳細
出版年:	Antimicrob Agents Chemother
主要な著者:	Kageyama, S, Anderson, B D, Hoesterey, B L, Hayashi, H, Kiso, Y, Flora, K P, Mitsuya, H
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1994
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188158/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8067746/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.5.1107
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins.

類似資料